speb/financial-data huggingface dataset:
CLNE cash_flow (quarterly, 2025-06-30) — Deferred Tax: 50000.00
CLNE cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 9962000.00
CLNE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 9962000.00
CLNE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 220393997.00
CLNE income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.09
CLNE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -20240000.00
CLNE income_statement (quarterly, 2025-06-30) — EBIT: -12601000.00
CLNE income_statement (quarterly, 2025-06-30) — EBITDA: -2639000.00
CLNE income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -6530000.00
CLNE cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 6530000.00
CLNE cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -56000.00
CLNE cash_flow (quarterly, 2025-06-30) — End Cash Position: 134203000.00
CLNE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -8277000.00
CLNE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 21193000.00
CLNE cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 544000.00
CLNE cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -14000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -2265000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Goodwill: 0.00
CLNE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 5500000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 85034000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 956269000.00
CLNE income_statement (quarterly, 2025-06-30) — Gross Profit: 18221000.00
CLNE income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
CLNE cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 20000.00
CLNE income_statement (quarterly, 2025-06-30) — Interest Expense: 7735000.00
CLNE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 7735000.00
CLNE income_statement (quarterly, 2025-06-30) — Interest Income: 3088000.00
CLNE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 3088000.00
CLNE cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: -3601000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Interest Payable: 1454000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Inventory: 45373000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 868744000.00
CLNE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -14044000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 255589000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 255589000.00
CLNE cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CLNE balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 20595000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Loans Receivable: 85000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 86564000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 277874000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 364438000.00
CLNE cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -318000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 255589000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 167803000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Minority Interest: 6026000.00
CLNE income_statement (quarterly, 2025-06-30) — Minority Interests: 168000.00
CLNE cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 1105000.00
CLNE cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -7547000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Net Debt: 145834000.00
CLNE income_statement (quarterly, 2025-06-30) — Net Income: -20240000.00
CLNE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -20240000.00
CLNE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -20408000.00
CLNE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -20240000.00
CLNE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -20240000.00
CLNE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -20408000.00
CLNE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -20408000.00
CLNE income_statement (quarterly, 2025-06-30) — Net Interest Income: -4647000.00
CLNE cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 428000.00
CLNE cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -318000.00
CLNE cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -318000.00
CLNE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -4647000.00
CLNE cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -412000.00
CLNE cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -879000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Net PPE: 411845000.00
CLNE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -14698000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 585321000.00
CLNE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -2639000.00
CLNE income_statement (quarterly, 2025-06-30) — Normalized Income: -20240000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Notes Receivable: 2809000.00
CLNE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 35901000.00
CLNE cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 7060000.00
CLNE income_statement (quarterly, 2025-06-30) — Operating Income: -9232000.00
CLNE income_statement (quarterly, 2025-06-30) — Operating Revenue: 102613000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 219187208.00
CLNE balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 25314000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 49000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -2265000.00
CLNE income_statement (quarterly, 2025-06-30) — Other Income Expense: -6457000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 5500000.00
CLNE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2312000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 35043000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 10306000.00
CLNE income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 73000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Other Properties: 666507000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Other Receivables: 6078000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 108669000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Payables: 28492000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 112494000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 4698000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CLNE income_statement (quarterly, 2025-06-30) — Pretax Income: -20336000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CLNE cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 796000.00
CLNE cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
CLNE cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -157572000.00
CLNE cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -14708000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Raw Materials: 45373000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Receivables: 94307000.00
CLNE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 84392000.00
CLNE income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 9962000.00
CLNE cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -318000.00
CLNE cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -7547000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 2114000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1167749000.00
CLNE cash_flow (quarterly, 2025-06-30) — Sale Of Business: 1105000.00
CLNE cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 158000000.00
CLNE cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 10000.00
CLNE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 27453000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Share Issued: 219187208.00
CLNE income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CLNE cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 19799000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 590821000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 585321000.00
CLNE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CLNE income_statement (quarterly, 2025-06-30) — Tax Provision: 72000.00
CLNE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CLNE balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 2474000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Total Assets: 1115843000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 868695000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Total Debt: 373824000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 596847000.00
CLNE income_statement (quarterly, 2025-06-30) — Total Expenses: 111845000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 518996000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 707977000.00
CLNE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 374744000.00
CLNE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -9232000.00
CLNE income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
CLNE income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
CLNE balance_sheet (quarterly, 2025-06-30) — Working Capital: 263614000.00
CLNE income_statement (quarterly, 2025-09-30) — +Operating Expense: 26270000.00
CLNE income_statement (quarterly, 2025-09-30) — +Total Revenue: 106137000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 32622000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 96156000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -553720000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1779955000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -2067000.00
CLNE cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
CLNE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 219290040.00
CLNE income_statement (quarterly, 2025-09-30) — Basic EPS: -0.11
CLNE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 134203000.00
CLNE cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -12180000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 97262000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 22000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 180841000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 232160000.00
CLNE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -767000.00
CLNE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 36678000.00
CLNE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 13088000.00
CLNE cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 4639000.00
CLNE cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 2040000.00
CLNE cash_flow (quarterly, 2025-09-30) — Change In Inventory: -942000.00
CLNE cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -1648000.00
CLNE cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 1575000.00
CLNE cash_flow (quarterly, 2025-09-30) — Change In Payable: 4639000.00
CLNE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 6679000.00
CLNE cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 499000.00
CLNE cash_flow (quarterly, 2025-09-30) — Change In Receivables: -13014000.00
CLNE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -6851000.00
CLNE cash_flow (quarterly, 2025-09-30) — Changes In Cash: 48999000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Common Stock: 22000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 585207000.00
CLNE cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 4000.00
CLNE cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
CLNE balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 109403000.00
CLNE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 93503000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 80892000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Current Assets: 409080000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 9845000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Current Debt: 51000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 9896000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 10423000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 10423000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 152348000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Current Provisions: 13893000.00
CLNE cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 51000.00
CLNE cash_flow (quarterly, 2025-09-30) — Deferred Tax: 51000.00
CLNE cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 14682000.00
CLNE cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 14682000.00
CLNE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 219290040.00
CLNE income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.11
CLNE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -23819000.00
CLNE income_statement (quarterly, 2025-09-30) — EBIT: -16146000.00
CLNE income_statement (quarterly, 2025-09-30) — EBITDA: -1464000.00
CLNE income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -7524000.00
CLNE cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 7524000.00
CLNE cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -247000.00
CLNE cash_flow (quarterly, 2025-09-30) — End Cash Position: 182955000.00
CLNE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -767000.00
CLNE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 908000.00
CLNE cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 319000.00
CLNE cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -81000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -3202000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Goodwill: 0.00
CLNE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 5500000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 98223000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Gross PPE: 967448000.00
CLNE income_statement (quarterly, 2025-09-30) — Gross Profit: 12634000.00
CLNE income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
CLNE cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 16000.00
CLNE income_statement (quarterly, 2025-09-30) — Interest Expense: 7782000.00
CLNE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 7782000.00
CLNE income_statement (quarterly, 2025-09-30) — Interest Income: 2876000.00
CLNE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2876000.00
CLNE cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 1404000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Interest Payable: 1455000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Inventory: 44421000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 869500000.00
CLNE cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 36678000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 262503000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 262503000.00
CLNE cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 4000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 20506000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 87417000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 284242000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 371659000.00
CLNE cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -297000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 262503000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 167939000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Minority Interest: 5842000.00
CLNE income_statement (quarterly, 2025-09-30) — Minority Interests: 184000.00
CLNE cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -12472000.00
CLNE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 4000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Net Debt: 103452000.00
CLNE income_statement (quarterly, 2025-09-30) — Net Income: -23819000.00
CLNE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -23819000.00
CLNE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -24003000.00
CLNE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -23819000.00
CLNE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -23819000.00
CLNE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -24003000.00
CLNE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -24003000.00
CLNE income_statement (quarterly, 2025-09-30) — Net Interest Income: -4906000.00
CLNE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 58458000.00
CLNE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -297000.00
CLNE cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -297000.00
CLNE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -4906000.00
CLNE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -474000.00
CLNE cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 2783000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Net PPE: 413728000.00
CLNE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -12091000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 579707000.00
CLNE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1464000.00
CLNE income_statement (quarterly, 2025-09-30) — Normalized Income: -23819000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Notes Receivable: 524000.00
CLNE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 13088000.00
CLNE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 5704000.00
CLNE income_statement (quarterly, 2025-09-30) — Operating Income: -13636000.00
CLNE income_statement (quarterly, 2025-09-30) — Operating Revenue: 106137000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 219293281.00
CLNE balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 25825000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 51000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -3202000.00
CLNE income_statement (quarterly, 2025-09-30) — Other Income Expense: -5386000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 5500000.00
CLNE cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 2448000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 34291000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 10046000.00
CLNE income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 2138000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Other Properties: 669600000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Other Receivables: 7080000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 51319000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Payables: 32622000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 113514000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 4622000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CLNE income_statement (quarterly, 2025-09-30) — Pretax Income: -23928000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CLNE cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 2088000.00
CLNE cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -13008000.00
CLNE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -166755000.00
CLNE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -12180000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Raw Materials: 44421000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Receivables: 104560000.00
CLNE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 93503000.00
CLNE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 14682000.00
CLNE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -297000.00
CLNE cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
CLNE balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 2114000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1191568000.00
CLNE cash_flow (quarterly, 2025-09-30) — Sale Of Business: 536000.00
CLNE cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 225213000.00
CLNE cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 89000.00
CLNE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 26270000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Share Issued: 219293281.00
CLNE income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CLNE cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 18969000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 585207000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 579707000.00
CLNE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CLNE income_statement (quarterly, 2025-09-30) — Tax Provision: 75000.00
CLNE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CLNE balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 800000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Total Assets: 1125102000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 869449000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Total Debt: 381555000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 591049000.00
CLNE income_statement (quarterly, 2025-09-30) — Total Expenses: 119773000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 534053000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 716022000.00
CLNE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 381705000.00
CLNE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -13636000.00
CLNE income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
CLNE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CLNE balance_sheet (quarterly, 2025-09-30) — Working Capital: 256732000.00
CLNE income_statement (annual, 2025-12-31) — +Operating Expense: 111838000.00
CLNE income_statement (quarterly, 2025-12-31) — +Operating Expense: 30651000.00
CLNE income_statement (annual, 2025-12-31) — +Total Revenue: 424833000.00
CLNE income_statement (quarterly, 2025-12-31) — +Total Revenue: 112319000.00
CLNE balance_sheet (annual, 2025-12-31) — Accounts Payable: 26176000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 26176000.00
CLNE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 100793000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 100793000.00
CLNE balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -494282000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -494282000.00
CLNE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1796957000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1796957000.00
CLNE balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2069000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2069000.00
CLNE cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 64328000.00
CLNE cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
CLNE income_statement (annual, 2025-12-31) — Basic Average Shares: 220648541.00
CLNE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 219299182.00
CLNE income_statement (annual, 2025-12-31) — Basic EPS: -1.01
CLNE income_statement (quarterly, 2025-12-31) — Basic EPS: -0.20
CLNE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 91562000.00
CLNE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 182955000.00
CLNE cash_flow (annual, 2025-12-31) — Capital Expenditure: -59884000.00
CLNE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -14406000.00
CLNE balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 98849000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 98849000.00
CLNE balance_sheet (annual, 2025-12-31) — Capital Stock: 22000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 22000.00
CLNE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 155584000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 155584000.00
CLNE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 156136000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 156136000.00
CLNE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -82111000.00
CLNE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -71143000.00
CLNE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 63099000.00
CLNE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 33068000.00
CLNE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 85529000.00
CLNE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 13112000.00
CLNE cash_flow (annual, 2025-12-31) — Change In Account Payable: -1590000.00
CLNE cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -151000.00
CLNE cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 10217000.00
CLNE cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 7498000.00
CLNE cash_flow (annual, 2025-12-31) — Change In Inventory: -4435000.00
CLNE cash_flow (quarterly, 2025-12-31) — Change In Inventory: -728000.00
CLNE cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -8402000.00
CLNE cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -2931000.00
CLNE cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 11476000.00
CLNE cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 7974000.00
CLNE cash_flow (annual, 2025-12-31) — Change In Payable: -1590000.00
CLNE cash_flow (quarterly, 2025-12-31) — Change In Payable: -151000.00
CLNE cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 8627000.00
CLNE cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 7347000.00
CLNE cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 2285000.00
CLNE cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 2337000.00
CLNE cash_flow (annual, 2025-12-31) — Change In Receivables: -2788000.00
CLNE cash_flow (quarterly, 2025-12-31) — Change In Receivables: -19845000.00
CLNE cash_flow (annual, 2025-12-31) — Change In Working Capital: 6763000.00
CLNE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -5846000.00
CLNE cash_flow (annual, 2025-12-31) — Changes In Cash: 66517000.00
CLNE cash_flow (quarterly, 2025-12-31) — Changes In Cash: -24963000.00
CLNE balance_sheet (annual, 2025-12-31) — Common Stock: 22000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Common Stock: 22000.00
CLNE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 559421000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 559421000.00
CLNE cash_flow (annual, 2025-12-31) — Common Stock Payments: -7975000.00
CLNE cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -37000.00
CLNE balance_sheet (annual, 2025-12-31) — Construction In Progress: 38250000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 38250000.00
CLNE income_statement (annual, 2025-12-31) — Cost Of Revenue: 408531000.00
CLNE income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 92366000.00
CLNE balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 90260000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 90260000.00
CLNE balance_sheet (annual, 2025-12-31) — Current Assets: 350339000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Current Assets: 350339000.00
CLNE balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 10398000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 10398000.00
CLNE balance_sheet (annual, 2025-12-31) — Current Debt: 52000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Current Debt: 52000.00
CLNE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 10450000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 10450000.00
CLNE balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 18423000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 18423000.00
CLNE balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 18423000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 18423000.00
CLNE balance_sheet (annual, 2025-12-31) — Current Liabilities: 151155000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 151155000.00
CLNE balance_sheet (annual, 2025-12-31) — Current Provisions: 746000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Current Provisions: 746000.00
CLNE cash_flow (annual, 2025-12-31) — Deferred Income Tax: -2876000.00
CLNE cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -22000.00
CLNE cash_flow (annual, 2025-12-31) — Deferred Tax: -2876000.00
CLNE cash_flow (quarterly, 2025-12-31) — Deferred Tax: -22000.00
CLNE cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 98606000.00
CLNE cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 11695000.00
CLNE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 98606000.00
CLNE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 11695000.00
CLNE income_statement (annual, 2025-12-31) — Diluted Average Shares: 220648541.00
CLNE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 219299182.00
CLNE income_statement (annual, 2025-12-31) — Diluted EPS: -1.01
CLNE income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.20
CLNE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -222024000.00
CLNE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -42998000.00
CLNE income_statement (annual, 2025-12-31) — EBIT: -172769000.00
CLNE income_statement (quarterly, 2025-12-31) — EBIT: -13587000.00
CLNE income_statement (annual, 2025-12-31) — EBITDA: -74163000.00
CLNE income_statement (quarterly, 2025-12-31) — EBITDA: -1892000.00
CLNE income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -26737000.00
CLNE income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -5639000.00
CLNE cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 26737000.00
CLNE cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 5639000.00
CLNE cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -323000.00
CLNE cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -236000.00
CLNE cash_flow (annual, 2025-12-31) — End Cash Position: 157756000.00
CLNE cash_flow (quarterly, 2025-12-31) — End Cash Position: 157756000.00
CLNE cash_flow (annual, 2025-12-31) — Financing Cash Flow: -82111000.00
CLNE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -71143000.00
CLNE cash_flow (annual, 2025-12-31) — Free Cash Flow: 25645000.00
CLNE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -1294000.00
CLNE cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -394000.00
CLNE cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -1814000.00
CLNE cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 2707000.00
CLNE cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -3000.00
CLNE balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2992000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2992000.00
CLNE balance_sheet (annual, 2025-12-31) — Goodwill: 0.00
CLNE balance_sheet (quarterly, 2025-12-31) — Goodwill: 0.00
CLNE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 9896000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 9896000.00
CLNE balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 102862000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 102862000.00
CLNE balance_sheet (annual, 2025-12-31) — Gross PPE: 906244000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 906244000.00
CLNE income_statement (annual, 2025-12-31) — Gross Profit: 16302000.00
CLNE income_statement (quarterly, 2025-12-31) — Gross Profit: 19953000.00
CLNE income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 64328000.00
CLNE income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
CLNE cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 41000.00
CLNE cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 3000.00
CLNE income_statement (annual, 2025-12-31) — Interest Expense: 52687000.00
CLNE income_statement (quarterly, 2025-12-31) — Interest Expense: 29642000.00
CLNE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 52687000.00
CLNE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 29642000.00
CLNE income_statement (annual, 2025-12-31) — Interest Income: 11383000.00
CLNE income_statement (quarterly, 2025-12-31) — Interest Income: 2520000.00
CLNE income_statement (annual, 2025-12-31) — Interest Income Non Operating: 11383000.00
CLNE income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 2520000.00
CLNE cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 14958000.00
CLNE cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 10893000.00
CLNE balance_sheet (annual, 2025-12-31) — Interest Payable: 1438000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Interest Payable: 1438000.00
CLNE balance_sheet (annual, 2025-12-31) — Inventory: 43906000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Inventory: 43906000.00
CLNE balance_sheet (annual, 2025-12-31) — Invested Capital: 786200000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 786200000.00
CLNE cash_flow (annual, 2025-12-31) — Investing Cash Flow: 63099000.00
CLNE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 33068000.00
CLNE balance_sheet (annual, 2025-12-31) — Investments And Advances: 262325000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 262325000.00
CLNE balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 262325000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 262325000.00
CLNE cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
CLNE balance_sheet (annual, 2025-12-31) — Land And Improvements: 20536000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 20536000.00
CLNE balance_sheet (annual, 2025-12-31) — Loans Receivable: 88000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 88000.00
CLNE balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 88451000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 88451000.00
CLNE balance_sheet (annual, 2025-12-31) — Long Term Debt: 226727000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 226727000.00
CLNE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 315178000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 315178000.00
CLNE cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
CLNE cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -66217000.00
CLNE cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -65346000.00
CLNE balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 262325000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 262325000.00
CLNE balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 241078000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 241078000.00
CLNE balance_sheet (annual, 2025-12-31) — Minority Interest: 5646000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Minority Interest: 5646000.00
CLNE income_statement (annual, 2025-12-31) — Minority Interests: 612000.00
CLNE income_statement (quarterly, 2025-12-31) — Minority Interests: 196000.00
CLNE cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -13129000.00
CLNE cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -3147000.00
CLNE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -7975000.00
CLNE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -93000.00
CLNE balance_sheet (annual, 2025-12-31) — Net Debt: 71195000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Net Debt: 71195000.00
CLNE income_statement (annual, 2025-12-31) — Net Income: -222024000.00
CLNE income_statement (quarterly, 2025-12-31) — Net Income: -42998000.00
CLNE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -222024000.00
CLNE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -42998000.00
CLNE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -222636000.00
CLNE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -43194000.00
CLNE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -222024000.00
CLNE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -42998000.00
CLNE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -222024000.00
CLNE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -42998000.00
CLNE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -222636000.00
CLNE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -43194000.00
CLNE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -222636000.00
CLNE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -43194000.00
CLNE income_statement (annual, 2025-12-31) — Net Interest Income: -41304000.00
CLNE income_statement (quarterly, 2025-12-31) — Net Interest Income: -27122000.00
CLNE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 131440000.00
CLNE cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 51469000.00
CLNE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -66217000.00
CLNE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -65346000.00
CLNE cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -66217000.00
CLNE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -65346000.00
CLNE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -41304000.00
CLNE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -27122000.00
CLNE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -7919000.00
CLNE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -5704000.00
CLNE cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -456000.00
CLNE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -879000.00
CLNE balance_sheet (annual, 2025-12-31) — Net PPE: 411962000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Net PPE: 411962000.00
CLNE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -54756000.00
CLNE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -14375000.00
CLNE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 549525000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 549525000.00
CLNE income_statement (annual, 2025-12-31) — Normalized EBITDA: -9835000.00
CLNE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -1892000.00
CLNE income_statement (annual, 2025-12-31) — Normalized Income: -158532264.00
CLNE income_statement (quarterly, 2025-12-31) — Normalized Income: -42998000.00
CLNE balance_sheet (annual, 2025-12-31) — Notes Receivable: 0.00
CLNE balance_sheet (quarterly, 2025-12-31) — Notes Receivable: 0.00
CLNE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 85529000.00
CLNE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 13112000.00
CLNE cash_flow (annual, 2025-12-31) — Operating Gains Losses: 51825000.00
CLNE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 28655000.00
CLNE income_statement (annual, 2025-12-31) — Operating Income: -95536000.00
CLNE income_statement (quarterly, 2025-12-31) — Operating Income: -10698000.00
CLNE income_statement (annual, 2025-12-31) — Operating Revenue: 424833000.00
CLNE income_statement (quarterly, 2025-12-31) — Operating Revenue: 112319000.00
CLNE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 219331992.00
CLNE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 219331992.00
CLNE balance_sheet (annual, 2025-12-31) — Other Current Assets: 41139000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 41139000.00
CLNE balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 52000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 52000.00
CLNE balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -2992000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2992000.00
CLNE income_statement (annual, 2025-12-31) — Other Income Expense: -88616000.00
CLNE income_statement (quarterly, 2025-12-31) — Other Income Expense: -5409000.00
CLNE balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 9896000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 9896000.00
CLNE cash_flow (annual, 2025-12-31) — Other Non Cash Items: 10542000.00
CLNE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 3809000.00
CLNE balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 22194000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 22194000.00
CLNE balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 25316000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 25316000.00
CLNE income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 2449000.00
CLNE income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 230000.00
CLNE balance_sheet (annual, 2025-12-31) — Other Properties: 606380000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Other Properties: 606380000.00
CLNE balance_sheet (annual, 2025-12-31) — Other Receivables: 5079000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Other Receivables: 5079000.00
CLNE balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 552000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 552000.00
CLNE balance_sheet (annual, 2025-12-31) — Payables: 26176000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Payables: 26176000.00
CLNE balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 116436000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 116436000.00
CLNE balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5100000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 5100000.00
CLNE balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CLNE balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CLNE income_statement (annual, 2025-12-31) — Pretax Income: -225456000.00
CLNE income_statement (quarterly, 2025-12-31) — Pretax Income: -43229000.00
CLNE balance_sheet (annual, 2025-12-31) — Properties: 0.00
CLNE balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CLNE cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 4007000.00
CLNE cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 928000.00
CLNE cash_flow (annual, 2025-12-31) — Purchase Of Business: -16488000.00
CLNE cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -3480000.00
CLNE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -854581000.00
CLNE cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -167014000.00
CLNE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -59884000.00
CLNE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -14406000.00
CLNE balance_sheet (annual, 2025-12-31) — Raw Materials: 43906000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Raw Materials: 43906000.00
CLNE balance_sheet (annual, 2025-12-31) — Receivables: 106986000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Receivables: 106986000.00
CLNE income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 408531000.00
CLNE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 92366000.00
CLNE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 98606000.00
CLNE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 11695000.00
CLNE cash_flow (annual, 2025-12-31) — Repayment Of Debt: -66217000.00
CLNE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -65346000.00
CLNE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -7975000.00
CLNE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -37000.00
CLNE balance_sheet (annual, 2025-12-31) — Restricted Cash: 2172000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 2172000.00
CLNE balance_sheet (annual, 2025-12-31) — Retained Earnings: -1234566000.00
CLNE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1234566000.00
CLNE cash_flow (annual, 2025-12-31) — Sale Of Business: 3359000.00
CLNE cash_flow (quarterly, 2025-12-31) — Sale Of Business: 333000.00
CLNE cash_flow (annual, 2025-12-31) — Sale Of Investment: 986021000.00
CLNE cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 218483000.00
CLNE cash_flow (annual, 2025-12-31) — Sale Of PPE: 5128000.00
CLNE cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 31000.00